Prostate Health Archive

Men who are diagnosed with certain types of prostate cancer often choose active surveillance, which allows them to delay the need for aggressive treatment. The results of a long-term study affirm that this approach is a valid option for managing the disease.

Men with low-risk prostate cancer continue to choose active surveillance as their course of action, meaning they monitor their cancer and don’t seek treatment unless it becomes worse. While this wait-and-see approach may appear passive in nature, it’s an opportunity for men to take charge of their health and make lifestyle changes that could improve their cancer outcome and offer protection against other health risks, like heart disease.

The increasing size and visibility of the transgender population has implications for public health. Hormone treatment given to transgender women lowers the overall risk of prostate cancer, but the risk of a trans woman developing the disease is not zero.

Doctors used to recommend treating all men with prostate cancer; now they are likely to advise active surveillance for lower-risk cancers. But some men require closer monitoring — so how do they determine which ones?

In some men who have prostate cancer surgery the cancer never returns, while in others it does. A new type of imaging technology indicates the presence of prostate tumors, and researchers wanted to know if this could be used to predict cancer recurrence after treatment.

Sexual side effects can be a primary concern when treating an enlarged prostate with medication or surgery. Depending on the treatment, side effects might include erectile dysfunction, low libido, reduced volume of ejaculation, or retrograde ejaculation, (in which semen travels backward into the bladder rather than out through the penis). Understanding the risks can help men with their treatment decision and to be better prepared if any sexual-related problems arise.

This year, results from a review of literature on plant-based diets and prostate cancer risk concluded that apart from having advantages for cardiovascular health, quality of life, and environmental benefits, plant-based diets have the potential to improve prostate cancer outcomes.

Hormonal therapy is a cornerstone of prostate cancer treatment, but it has burdensome side effects. Doctors and patients alike are highly motivated to use this therapy only for as long as necessary. But how long is long enough? A recent study provides needed clarity.

Over-the-counter supplements touted to support prostate health are popular, and supposedly help prevent and manage symptoms of an enlarged prostate (benign prostate hyperplasia). Some of the ingredients are said to protect against prostate cancer or slow its growth. While research has explored supplements' role in prostate health and some had positive results, the findings are far from conclusive. A better dietary option for prostate health is to follow a plant-based diet like the Mediterranean or DASH diet.

When prostate cancer spreads beyond the gland, it has been treated with hormone therapy, but there are challenging side effects. A new study shows that a different treatment option involving radiation can allow some men to delay or avoid hormone therapy.